Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 18:1_19:1_22:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003760 AN006174 Untargeted lipidomics of combination gemcitabine/paclitaxel attenuated (CombAT) PDAC cells Pancreas Human Cancer Victor Chang Cardiac Research Institute LC-MS
ST003757 AN006168 Untargeted lipidomics of gemcitabine-resistant PDAC cells Pancreas Human Cancer Victor Chang Cardiac Research Institute LC-MS
ST003629 AN005962 Impact of human PSMC5 gene mutations on neuronal development: Lipid profiling of PSMC5 mutant T cells T-cells Human Brain disease Leibniz Institute for Plasma Science and Technology LC-MS
ST003341 AN005475 Untargeted Lipidomic Profiling of Canine Cancer Cell Lines Cultured cells Dog Cancer Kojin Therapeutics, Inc. LC-MS
  logo